Cargando…

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

Detalles Bibliográficos
Autores principales: Tajika, Aran, Furukawa, Toshi A, Shinohara, Kiyomi, Kikuchi, Shino, Toyomoto, Rie, Furukawa, Yuki, Ito, Masami, Yoshida, Kazufumi, Honda, Yukiko, Takayama, Tomohiro, Schneider-Thoma, Johannes, Leucht, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124187/
https://www.ncbi.nlm.nih.gov/pubmed/37085286
http://dx.doi.org/10.1136/bmjment-2023-300654
_version_ 1785029788283437056
author Tajika, Aran
Furukawa, Toshi A
Shinohara, Kiyomi
Kikuchi, Shino
Toyomoto, Rie
Furukawa, Yuki
Ito, Masami
Yoshida, Kazufumi
Honda, Yukiko
Takayama, Tomohiro
Schneider-Thoma, Johannes
Leucht, Stefan
author_facet Tajika, Aran
Furukawa, Toshi A
Shinohara, Kiyomi
Kikuchi, Shino
Toyomoto, Rie
Furukawa, Yuki
Ito, Masami
Yoshida, Kazufumi
Honda, Yukiko
Takayama, Tomohiro
Schneider-Thoma, Johannes
Leucht, Stefan
author_sort Tajika, Aran
collection PubMed
description
format Online
Article
Text
id pubmed-10124187
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-101241872023-08-21 Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review Tajika, Aran Furukawa, Toshi A Shinohara, Kiyomi Kikuchi, Shino Toyomoto, Rie Furukawa, Yuki Ito, Masami Yoshida, Kazufumi Honda, Yukiko Takayama, Tomohiro Schneider-Thoma, Johannes Leucht, Stefan BMJ Ment Health Correspondence BMJ Publishing Group 2023-04-21 /pmc/articles/PMC10124187/ /pubmed/37085286 http://dx.doi.org/10.1136/bmjment-2023-300654 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correspondence
Tajika, Aran
Furukawa, Toshi A
Shinohara, Kiyomi
Kikuchi, Shino
Toyomoto, Rie
Furukawa, Yuki
Ito, Masami
Yoshida, Kazufumi
Honda, Yukiko
Takayama, Tomohiro
Schneider-Thoma, Johannes
Leucht, Stefan
Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title_full Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title_fullStr Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title_full_unstemmed Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title_short Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
title_sort blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124187/
https://www.ncbi.nlm.nih.gov/pubmed/37085286
http://dx.doi.org/10.1136/bmjment-2023-300654
work_keys_str_mv AT tajikaaran blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT furukawatoshia blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT shinoharakiyomi blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT kikuchishino blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT toyomotorie blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT furukawayuki blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT itomasami blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT yoshidakazufumi blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT hondayukiko blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT takayamatomohiro blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT schneiderthomajohannes blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview
AT leuchtstefan blindingsuccessfulnessinantipsychotictrialsofacutetreatmentforschizophreniaasystematicreview